Skip to content

Scilex Holding Company SCLX Other accrued liabilities

Other accrued liabilities at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
Viatris logo
ViatrisVTRS
PTH
Pelthos Therapeutics Inc.PTHS
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Scilex Holding Company’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's other accrued liabilities?
Scilex Holding Company (SCLX) reported other accrued liabilities of $247.51M in Q1 2026.
How has Scilex Holding Company's other accrued liabilities changed year-over-year?
Scilex Holding Company's other accrued liabilities increased by 47.0% year-over-year, from $168.43M to $247.51M.
What is the long-term trend for Scilex Holding Company's other accrued liabilities?
Over 5 years (2020 to 2025), Scilex Holding Company's other accrued liabilities has grown at a 517.8% compound annual growth rate (CAGR), from $25.76K to $231.76M.